Acoramidis is a pharmaceutical compound developed as a near-complete transthyretin stabilizer, used in the manufacture of medications for cardiomyopathy. It is designed to mimic the protective properties of a naturally occurring mutation.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1446711-81-4
Acoramidis hydrochloride
pharmaceutical raw material
Olmesartan
pharmaceutical raw material
Olmesartan medoxomil
pharmaceutical raw material
Telmisartan
pharmaceutical raw material
Telmisartan tert-butyl ester
pharmaceutical raw material
3-[3-(3,5-dimethyl-1H-pyrazol-4-yl)propoxy]-4-fluorobenzoic acid
WBFUHHBPNXWNCC-UHFFFAOYSA-N
CC1=C(C(=NN1)C)CCCOC2=C(C=CC(=C2)C(=O)O)F